The University of Chicago Header Logo

Connection

Matthew J. Brady to Phosphatidylinositol 3-Kinase

Back to Details
This is a "connection" page, showing publications Matthew J. Brady has written about Phosphatidylinositol 3-Kinase.
Matthew J. Brady
Connection Strength
0.106
Phosphatidylinositol 3-Kinase
  1. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.